SCCS Final Opinion on HAA299 (Nano)
HAA299 (non-nano) has been used in cosmetic products as a UV filter. In 2014, the SCCS considered that this ingredient in its non-nano form was safe for use as a UV-filter in cosmetics, at a maximum concentration of 10%. The SCCS released its final opinion regarding the use of HAA299 in its nano form.
Marta Pinto

Marta Pinto

Regulatory Affairs Associate


HAA299 (CAS number: 919803-06-8), also called Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (INCI name) is an organic compound used as a UV-filter in cosmetics and personal care products. HAA299 (nano form and non-nano) is not currently included in the Annexes of the European Cosmetics Regulation (Regulation (EC) No 1223/2009).

In 2014, the European Commission’s Scientific Committee on Consumer Safety (SCCS) issued an opinion regarding the use of HAA299 as UV filter in sunscreen products. The SCCS concluded that the use of non-nano HAA299 (micronized or non-micronized, with median particle size distribution around 134 nm or larger) at a concentration up to 10% as an UV-filter in cosmetic products, does not pose a risk of systemic toxicity in humans. The SCCS safety evaluation does not apply to inhalation exposure and covered only the HAA299 in the non-nano form, not covering when this ingredient is composed of nano particles.

HAA299 has low oral bioavailability and scientific evidence shows an overall very low or lack of dermal absorption of HAA299 in human skin. Non-micronized HAA299 was not a dermal irritant when applied in rabbits but it caused slight irritation in the eyes of rabbits. No delayed contact hypersensitivity was observed in a murine Local Lymph Node Assay (LLNA), but the sensitization potential of HAA299 could not be ruled out by the SCCS. Phototoxicity studies with HAA299 indicate that this ingredient has no phototoxic, photoallergic or photogenotoxic potential.


The SCCS released its new opinion regarding the safety of HAA299 in its nano-form (aqueous dispersion of nanoparticles formulation with excipients containing the HAA299 active UV filter ingredient that was micronized to nano size).

The available data indicated that HAA299 in the nano-form is a practically insoluble material, with very low dermal and oral absorption. Nano HAA299 did not show skin irritation potential or caused ocular corrosion or severe ocular irritation in in vitro tests. Skin sensitizing and phototoxic potential are considered unlikely.

The SCCS expressed concerns regarding the repeated use of products containing nano HAA299, due to the inflammatory effects on the lung after acute inhalation exposure. The Committee does not recommend the use of this ingredient in applications that could lead to exposure of the consumer’s lungs via inhalation.

Considering the currently available scientific evidence, which shows an overall very low or lack of dermal absorption of nano HAA299, the SCCS considers that “HAA299, either as non-nano or nano form, is safe when used as a UV-filter in dermally-applied cosmetic products up to a maximum concentration of 10%”. Moreover, the Committee indicated that the combined maximum concentration of the two forms (nano and non-nano) should not exceed 10% in cosmetic products.

The SCCS may consider the revision of its opinion if new evidence emerges in the future to show that nano HAA299 used as UV-filter in cosmetic products can penetrate human skin to reach viable cells in higher levels than demonstrated in the submission.

If you wish to get more information on the safety of cosmetic ingredients, feel free to contact us at


  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Scientific Committee on Consumer Safety (SCCS). Opinion on HAA299 (nano). SCCS/1634/21. 2021
  3. Scientific Committee on Consumer Safety (SCCS). Opinion on 2-(4-(2-(4-Diethylamino-2-hydroxy-benzoyl)-benzoyl)- piperazine-1-carbonyl)-phenyl)- (4-diethylamino-2- hydroxyphenyl)-methanone (HAA299) as UV filter in sunscreen products. SCCS/1533/14. 2014


cosmetic products

EU to set Labelling Requirements for 56 additional Fragrance Allergens in Cosmetic Products

World Trade Organization (WTO) has been notified by the European Commission of a draft amendment to Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in Cosmetic Products. The proposed date of adoption of the new regulation is expected to be in the first half of 2023 and the propose date of entry in force 20 days from the publication in the Official Journal of the European Union.

Read More »
cosmetic products

New Amendments to the European Cosmetics Regulation – CMR Substances

The European Commission published the Commission Regulation (EU) 2022/1531, which amends Regulation (EC) No 1223/2009 in regards to the use in cosmetic products of certain substances classified as CMR. This amendment introduces new entries to Annex II and Annex III and revises an entry to Annex V to Regulation (EC) No 1223/2009.

Read More »
medical devices

EUDAMED – harmonized practices and alternative solutions for IVDR until the database is fully functional

EUDAMED is one of the key aspects of the new rules on in vitro diagnostic medical devices – Regulation (EU) 2017/746. However, it is only expected to achieve full functionality by the second quarter of 2024. Until then, how is the information submitted and/or exchanged between manufacturers, notified bodies and competent authorities?

Read More »
medical devices

EUDAMED – update on timelines

EUDAMED is one of the key aspects of the new rules on medical devices (Regulation (EU) 2017/745) and in vitro diagnostic medical devices (Regulation (EU) 2017/746), and it is expected to achieve full functionality by the second quarter of 2024.

Read More »
cosmetic products

UK OPSS call for data on six cosmetic ingredients

On 14 July 2022, the Office for Product Safety and Standards (OPSS – the UK regulator for cosmetic products) issued a call for data on the safety of the following six cosmetic ingredients to investigate any suspected endocrine disrupting properties. 

Read More »
cosmetic products

European Commission Recommendation on the Definition of Nanomaterial

Nanomaterials are increasingly used in cosmetics and personal care products. They are similar to other chemicals/substances, but with specific risks associated to their use. The European Commission has published a new Recommendation to clarify the definition of ‘nanomaterial’. This definition may serve different policy, legislative and research purposes when addressing materials or issues concerning products of nanotechnologies.

Read More »